Jing Zhi Lo

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

25

H-Index

1

About

Jing Zhi Lo is a distinguished urologic oncologist whose research focuses on the surgical management of advanced renal cell carcinoma, particularly cases involving vena cava tumor thrombus. His most-cited work, "Trends and outcomes in contemporary management of renal cell carcinoma and vena cava thrombus" (2019, 25 citations), provides a critical analysis of evolving surgical techniques and perioperative outcomes for this complex, high-risk condition. This study has become a key reference for clinicians navigating the challenges of thrombectomy and nephrectomy in patients with locally advanced disease. Lo's contributions have helped refine risk stratification and surgical decision-making, improving survival rates and reducing complications. His work underscores the importance of multidisciplinary care and advances in minimally invasive approaches, offering hope for patients with historically poor prognoses. With a growing influence in urologic oncology, Lo continues to shape clinical practice through evidence-based insights into aggressive renal tumors.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Trends and outcomes in contemporary management renal cell carcinoma and vena cava thrombus
25 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago